STOCK TITAN
  1. Home
  2. Sec-filings
  3. EVLV
  4. [8-K] Evolv Technologies Holdings, Inc. Reports Material Event

Revenue jumps 45% as Evolv (NASDAQ: EVLV) lifts 2026 outlook

Filing Impact
(High)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Evolv Technologies Holdings is clarifying that some market data sites misreported its recent revenue figures and outlook. The company confirms Q1 2026 total revenue was $46.3 million, up from $32.0 million in Q1 2025, a 45% year-over-year increase.

Evolv also confirms it has raised its full-year 2026 total revenue guidance range to $175 million to $180 million. The update is meant to ensure investors are relying on the company’s own disclosures rather than incorrect third-party data.

Positive

  • Q1 2026 revenue growth: Total revenue reached $46.3 million, up from $32.0 million in Q1 2025, a 45% year-over-year increase that indicates strong business expansion.
  • Raised full-year outlook: Management increased full-year 2026 total revenue guidance to a range of $175 million to $180 million, signaling higher expected sales than previously indicated.

Negative

  • None.

Insights

Evolv confirms strong 45% Q1 revenue growth and raises 2026 guidance.

Evolv Technologies Holdings is correcting third-party data errors by restating its own numbers. Q1 2026 total revenue was $46.3 million versus $32.0 million a year earlier, reflecting 45% year-over-year growth, which signals rapid topline expansion.

The company also increased its full-year 2026 total revenue guidance to a range of $175 million to $180 million. This higher outlook, directly from management, becomes the key reference point for assessing future performance versus expectations.

Because the update sits under Regulation FD, it is aimed at keeping all investors equally informed. Subsequent quarterly reports for periods ending after March 31, 2026 will show whether actual results track this new revenue range.

Item 7.01 Regulation FD Disclosure Disclosure
Material non-public information disclosed under Regulation Fair Disclosure, often investor presentations or guidance.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
Q1 2026 revenue $46.3 million Total revenue for the three-month period ended March 31, 2026
Q1 2025 revenue $32.0 million Total revenue for the three-month period ended March 31, 2025
Year-over-year revenue growth 45% Growth from Q1 2025 to Q1 2026
2026 revenue guidance low end $175 million Lower bound of full-year 2026 total revenue guidance
2026 revenue guidance high end $180 million Upper bound of full-year 2026 total revenue guidance
Regulation FD regulatory
"Item 7.01 Regulation FD Disclosure. Evolv Technologies Holdings, Inc. (the “Company”) has issued this"
Regulation FD is a rule that prevents company insiders, like executives, from sharing important information with some people before others get it. It matters because it helps ensure all investors have equal access to key news, making the stock market fairer and reducing chances of insider trading.
guidance financial
"and guidance for the full year, in each case, relating to revenue."
Guidance is the information that a company provides about its expected future performance or plans. It helps investors understand what the company aims to achieve and whether it anticipates growth or challenges ahead, much like a weather forecast helps people prepare for upcoming conditions. This information influences investment decisions by giving a clearer picture of the company's outlook.
forward-looking statements regulatory
"This on contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995."
Forward-looking statements are predictions or plans that companies share about what they expect to happen in the future, like estimating sales or profits. They matter because they help investors understand a company's outlook, but since they are based on guesses and assumptions, they can sometimes be wrong.
Emerging growth company regulatory
"Emerging growth company"
An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.
total revenue financial
"the Company’s total revenue was $46.3 million for the first quarter of 2026"
Understanding 8-K Material Events →
0001805385False00018053852026-05-132026-05-130001805385us-gaap:CommonClassAMember2026-05-132026-05-130001805385evlv:WarrantsToPurchaseOneShareOfClassCommonStockMember2026-05-132026-05-13

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): May 13, 2026
Evolv Technologies Holdings, Inc.
(Exact name of registrant as specified in its charter)
Delaware
001-39417
84-4473840
(State or other jurisdiction
of incorporation)
(Commission
File Number)
(IRS Employer
Identification No.)
500 Totten Pond Road, 4th Floor
Waltham, Massachusetts
02451
(Address of principal executive offices)
(Zip Code)
(781) 374-8100
Registrant’s telephone number, including area code
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which
registered
Class A common stock, par value $0.0001 per share
EVLV
The Nasdaq Stock Market
Warrants to purchase one share of Class A common stock
EVLVW
The Nasdaq Stock Market
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐


Item 7.01    Regulation FD Disclosure.

Evolv Technologies Holdings, Inc. (the “Company”) has issued this Current Report on Form 8-K to notify stockholders that certain market data websites misreported the Company’s financial results for the three-month period ended March 31, 2026 and guidance for the full year, in each case, relating to revenue.

These results and guidance were correctly reported in the press release that was issued by the Company on May 12, 2026, and furnished in Exhibit 99.1 to its Current Report on Form 8-K that was filed on May 12, 2026. To confirm, the Company’s total revenue was $46.3 million for the first quarter of 2026, representing 45% year-over-year growth compared to $32.0 million in the first quarter of 2025, and the Company raised its full year total revenue guidance range to $175 million to $180 million.

The information in this Item 7.01 of this Current Report on Form 8-K shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.

Forward-Looking Statements

This Current Report on Form 8-K contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. We intend such forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. All statements contained in this report other than statements of historical facts, including without limitation statements regarding our future financial results. The forward-looking statements in this report are only predictions and our actual future results may be materially different from what we expect. We have based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our business, financial condition and results of operations. Forward-looking statements involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements, including, but not limited to, the risks discussed in our most recent report on Form 10-Q or 10-K filed with the SEC could cause actual results to differ materially from those indicated by the forward-looking statements made in this report. The forward-looking statements in this report are based upon information available to us as of the date hereof, and while we believe such information forms a reasonable basis for such statements, it may be limited or incomplete, and our statements should not be read to indicate that we have conducted an exhaustive inquiry into, or review of, all potentially available relevant information. These statements are inherently uncertain and investors are cautioned not to unduly rely upon these statements. Except as required by applicable law, we do not plan to publicly update or revise any forward-looking statements contained in this report, whether as a result of any new information, future events or otherwise.
Item 9.01    Financial Statements and Exhibits.
(d) Exhibits
Exhibit No.
Description
104
Cover Page Interactive Data File (embedded within the Inline XBRL document)


SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Evolv Technologies Holdings, Inc.
Date: May 13, 2026
By:
/s/ John Kedzierski
Name:
John Kedzierski
Title:
Chief Executive Officer

Source: View Original Filing on SEC EDGAR

FAQ

What Q1 2026 revenue did Evolv Technologies Holdings (EVLV) confirm?

Evolv confirmed Q1 2026 total revenue of $46.3 million. This compares to $32.0 million in Q1 2025, representing 45% year-over-year growth in revenue for the period ended March 31, 2026.

Why did Evolv Technologies Holdings (EVLV) issue this 8-K under Regulation FD?

Evolv issued the update to correct misreported revenue data on certain market websites. The company wanted investors to rely on its own disclosed Q1 2026 results and full-year guidance rather than inaccurate third-party figures.

What full-year 2026 revenue guidance did Evolv (EVLV) provide?

Evolv raised its full-year 2026 total revenue guidance to $175 million to $180 million. This range reflects management’s current expectations for sales in 2026 based on recent performance and outlook assumptions.

How fast is Evolv’s revenue growing year over year?

For Q1 2026, Evolv reported 45% year-over-year revenue growth. Total revenue increased from $32.0 million in the first quarter of 2025 to $46.3 million in the first quarter of 2026, showing rapid expansion.

Does this Evolv 8-K change previously issued Q1 2026 financial results?

The 8-K does not change Evolv’s previously issued results; it reconfirms them. The company reiterates its Q1 2026 revenue and updated 2026 guidance because some market data sites displayed incorrect numbers.

What period do the confirmed Evolv (EVLV) results in this 8-K cover?

The confirmed financial results relate to the three-month period ended March 31, 2026. Evolv’s Q1 2026 revenue of $46.3 million and related year-over-year growth are specific to this quarter.

Filing Exhibits & Attachments

4 documents

Other Documents